The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Thu., Mar. 4, 2:01 PM

Slide #8. Bio-Techne Corporation Asuragen, Inc.

Acquirer: Bio-Techne Corporation (NASDAQ:TECH)
Acquiree: Asuragen, Inc.
Details: Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Asuragen, Inc. for initial consideration of $215 million in cash plus contingent consideration of up to $105 million upon the achievement of certain future milestones. The transaction will be financed through a combination of cash on hand and an existing revolving line of credit. Bio-Techne anticipates the acquisition to close in the fourth quarter of its fiscal 2021.

Bio-Techne and its subsidiaries develop, manufacture and sell life science reagents, instruments and services for the research and clinical diagnostic markets.Co.'s segments include: Protein Sciences, which developes and manufactures purified proteins and reagent solutions, cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies; and Diagnostics and Genomics, which develops and manufactures diagnostic products, including Food and Drug Administration-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for Original Equipment Manufacturer.

TECH SEC Filing Email Alerts Service


Open the TECH Page at The Online Investor »

Company Name: 
Bio-Techne Corp
Stock buyback: 
TECH buyback
Website: 
www.bio-techne.com
Sector: 
Biotechnology
Number of ETFs Holding TECH: 
75
Total Market Value Held by ETFs: 
$2.26B
Total Market Capitalization: 
$14.57B
% of Market Cap. Held by ETFs: 
15.52%
 

Open the TECH Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.33 out of 4)
46th percentile
(ranked lower than approx. 54% of all stocks covered)

Analysts' Target Price:
TECH Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.